Hedgehog signaling pathway
The hedgehog signaling pathway is one of the key regulators of animal development conserved from flies to humans. The pathway takes its name from its polypeptide ligand, an intercellular signaling molecule called Hedgehog (Hh) found in fruit flies of the genus Drosophila. Hh is one of Drosophila's segment polarity gene products, involved in establishing the basis of the fly body plan. The molecule remains important during later stages of embryogenesis and metamorphosis.
Mammals have three Hedgehog homologues, of which Sonic hedgehog is the best studied. The pathway is equally important during vertebrate embryonic development. In knockout mice lacking components of the pathway, the brain, skeleton, musculature, gastrointestinal tract and lungs fail to develop correctly. Recent studies point to the role of hedgehog signaling in regulating adult stem cells involved in maintenance and regeneration of adult tissues. The pathway has also been implicated in the development of some cancers. Drugs that specifically target hedgehog signaling to fight this disease are being actively developed by a number of pharmaceutical companies.
In 1995 Edward B. Lewis, Christiane Nüsslein-Volhard and Eric F. Wieschaus were awarded a Nobel Prize for their work producing and studying genetic mutations in Drosophila embryogenesis. In the 1970s, a fundamental problem in developmental biology was to understand how a relatively simple egg can give rise to a complex segmented body plan. Nüsslein-Volhard and Wieschaus attempted to isolate mutations in genes that control development of the segmented anteror-posterior body axis of the fly; their "saturation mutagenesis" technique resulted in the discovery of a group of genes involved in the development of body segmentation.
The Drosophila hedgehog gene was identified as one of several genes important for creating the differences between the anterior and posterior parts of individual body segments. Some hedgehog mutants result in abnormally-shaped embryos that are unusually short and stubby compared to wild type embryos. The function of the hedgehog segment polarity gene has been studied in terms of its influence on the normally polarized distribution of larval cuticular denticles as well as features on adult appendages such as legs and antennae. Rather than the normal pattern of denticles, hedgehog mutant larvae tend to have "solid lawns" of denticles (Figure 1). The appearance of the stubby and "hairy" larvae inspired the name 'hedgehog' (see: Hedgehog, the animal).
Insect cells express a full size zinc-finger transcription factor Cubitus interruptus (Ci), which forms a complex with the kinesin-like protein Costal-2 (Cos2) and is localized in the cytoplasm bound to cellular microtubules (Figure 2). The complex targets the Ci protein for proteosome-dependent cleavage, which generates a fragment (CiR) that functions as a transcriptional repressor. CiR builds up in the cell and diffuses into the nucleus, where it acts as a co-repressor for Hh target genes. The steps leading to Ci protein proteolysis include phosphorylation of Ci protein by several protein kinases; PKA, GSK3β and CK1 (Figure 2). The Drosophila protein Slimb is part of an SCF complex that targets proteins for ubiquitylation. Slimb binds to phosphorylated Ci protein.
In the absence of Hh (Figure 2), a cell-surface transmembrane protein called Patched (PTCH) acts to prevent high expression and activity of a 7 membrane spanning receptor called Smoothened (SMO). Patched has sequence similarity to known membrane transport proteins. When extracellular Hh is present (Figure 3), it binds to and inhibits Patched, allowing Smoothened to accumulate and inhibit the proteolytic cleavage of the Ci protein. This process most likely involves the direct interaction of Smoothened and Costal-2 and may involve sequestration of the Ci protein-containing complex to a microdomain where the steps leading to Ci protein proteolysis are disrupted. The mechanism by which Hh binding to Patched leads to increased levels of Smoothened is not clear (Step 1 in Figure 3). Following binding of Hh to Patched, Smoothened levels increase greatly over the level maintained in cells when Patched is not bound to Hh. It has been suggested that phosphorylation of Smoothened plays a role in Hh-dependent regulation of Smoothened levels.
In cells with Hh-activated Patched (Figure 3), the intact Ci protein accumulates in the cell cytoplasm and levels of CiR decrease, allowing transcription of some genes such as decapentaplegic (dpp, a member of the BMP growth factor family). For other Hh-regulated genes, expression requires not only loss of CiR but also the positive action of uncleaved Ci acting as a transcriptional activator . Costal-2 is normally important for holding Ci protein in the cytoplasm, but interaction of Smoothened with Costal-2 allows some intact Ci protein to go to the nucleus. The Drosophila protein Fused (Fu in Figure 3) is a protein kinase that binds to Costal-2. Fused can inhibit Suppressor of Fused (SUFU), which in turn interacts with Ci to regulate gene transcription in some cell types.
Hedgehog has roles in larval body segment development and in formation of adult appendages. During the formation of body segments in the developing Drosophila embryo, stripes of cells that synthesize the transcription factor Engrailed can also express the cell-to-cell signaling protein Hedgehog (green in Figure 4). Hedgehog is not free to move very far from the cells that make it and so it only activates a thin stripe of cells adjacent to the Engrailed-expressing cells. Only cells to one side of the Engrailed-expressing cells are competent to respond to Hedgehog following interaction of Hh with the receptor protein Patched (blue in Figure 4).
Cells with Hh-activated Patched receptor synthesize the Wingless protein (red in Figure 4). If a Drosophila embryo is altered so as to produce Hh in all cells, all of the competent cells respond and form a broader band of Wingless-expressing cells in each segment. The wingless gene has an upstream transcription regulatory region that binds the Ci transcription factor in a Hh-dependent fashion resulting in an increase in wingless transcription (interaction 2 in Figure 3) in a stripe of cells adjacent to the stripe of Hh-producing cells.
Wingless protein acts as an extracelluar signal and patterns the adjacent rows of cells by activating its cell surface receptor Frizzled. Wingless acts on Engrailed-expressing cells to stabilize the stripes of Engrailed expression. Wingless is a member of the Wnt family of cell-to-cell signaling proteins. The reciprocal signaling by Hedgehog and Wingless stabilizes the boundary between parasegments (Figure 4, top). The effects of Wingless and Hedgehog on other stripes of cells in each segment establishes a positional code that accounts for the distinct anatomical features along the anterior-posterior axis of the segments .
The Wingless protein is called "wingless" because of the phenotype of some wingless fly mutants. Wingless and Hedgehog functioned together during metamorphosis to coordinate wing formation. Hedgehog is expressed in the posterior part of developing Drosophila limbs. Hedgehog also participates in the coordination of eye, brain, gonad, gut and tracheal development.
Sonic hedgehog (SHH) is the best studied ligand of the vertebrate pathway. Most of what is known about hedgehog signaling has been established by studying SHH. It is translated as a ~45kDa precursor and undergoes autocatalytic processing to produce an ~20kDa N-terminal signaling domain (referred to as SHH-N) and a ~25kDa C-terminal domain with no known signaling role (1 on figure 5). During the cleavage, a cholesterol molecule is added to the carboxyl end of the N-terminal domain, which is involved in trafficking, secretion and receptor interaction of the ligand. SHH can signal in an autocrine fashion, affecting the cells in which it is produced. Secretion and consequent paracrine hedgehog signaling require the participation of Dispatched protein(2).
When SHH reaches its target cell, it binds to the Patched-1 (PTCH1) receptor(3). In the absence of ligand, PTCH1 inhibits Smoothened (SMO), a downstream protein in the pathway(4). It has been suggested that SMO is regulated by a small molecule, the cellular localisation of which is controlled by PTCH. PTCH1 has homology to Niemann-Pick disease, type C1 (NPC1) that is known to transport lipophilic molecules across a membrane.  PTCH1 has a sterol sensing domain (SSD), which has been shown to be essential for suppression of Smo activity. A current theory of how PTCH regulates SMO is by removing oxysterols from SMO. PTCH acts like a sterol pump and remove oxysterols that have been created by 7-dehydrocholesterol reductase. Upon binding of a Hh protein or a mutation in the SSD of PTCH the pump is turned off allowing oxysterols to accumulate around SMO.
This accumulation of sterols allows SMO to become active or stay on the membrane for a longer period of time. This hypothesis is supported by the existence of a number of small molecule agonists and antagonists of the pathway that act on SMO. The binding of SHH relieves SMO inhibition, leading to activation of the GLI transcription factors(5): the activators Gli1 and Gli2 and the repressor Gli3. The sequence of molecular events that connect SMO to GLIs is poorly understood. Activated GLI accumulates in the nucleus(6) and controls the transcription of hedgehog target genes(7). PTCH1 has recently been reported to repress transcription of hedgehog target genes through a mechanism independent of Smoothened.
In addition to PTCH1, mammals have another hedgehog receptor PTCH2 whose sequence identity with PTCH1 is 54%. All three mammalian hedgehogs bind both receptors with similar affinity, so PTCH1 and PTCH2 cannot discriminate between the ligands. They do, however, differ in their expression patterns. PTCH2 is expressed at much higher levels in the testis and mediates desert hedgehog signaling there. It appears to have a distinct downstream signaling role from PTCH1. In the absence of ligand binding PTCH2 has a decreased ability to inhibit the activity of SMO. Furthermore, overexpression of PTCH2 does not replace mutated PTCH1 in basal cell carcinoma.
In invertebrates, just as in Drosophila, the binding of hedgehog to PTCH leads to internalisation and sequestration of the ligand. Consequently in vivo the passage of hedgehog over a receptive field that expresses the receptor leads to attenuation of the signal, an effect called ligand-dependent antagonism (LDA). In contrast to Drosophila, vertebrates possess another level of hedgehog regulation through LDA mediated by Hh-interacting protein 1 (HHIP1). HHIP1 also sequesters hedgehog ligands, but unlike PTCH, it has no effect on the activity of SMO.
Members of the hedgehog family play key roles in a wide variety of developmental processes. One of the best studied examples is the action of Sonic hedgehog during development of the vertebrate limb. The classic experiments of Saunders and Gasseling in 1968 on the development of the chick limb bud formed the basis of the morphogen concept. They showed that identity of the digits in the chick limb was determined by a diffusible factor produced by the zone of polarizing activity (ZPA), a small region of tissue at the posterior margin of the limb. Mammalian development appeared to follow the same pattern. This diffusible factor was later shown to be Sonic hedgehog. However, precisely how SHH determines digit identity remained elusive until recently. The current model, proposed by Harfe et al, states that both the concentration and the time of exposure to SHH determines, which digit the tissue will develop into in the mouse embryo (figure 6).
Digits V, IV and part of III arise directly from cells that express SHH during embryogenesis. In these cells SHH signals in an autocrine fashion and these digits develop correctly in the absence of DISP, which is required for extracellular diffusion of the ligand. These digits differ in the length of time that SHH continues to be expressed. The most posterior digit V develops from cells that express the ligand for the longest period of time. Digit IV cells express SHH for a shorter time, and digit III cells shorter still. Digit II develops from cells that are exposed to moderate concentrations of extracellular SHH. Finally, digit I development does not require SHH. It is, in a sense, the default program of limb bud cells.
Hedgehog signaling remains important in the adult. Sonic hedgehog has been shown to promote the proliferation of adult stem cells from various tissues, including primitive hematopoietic cells, mammary and neural stem cells. Activation of the hedgehog pathway is required for transition of the hair follicle from the resting to the growth phase. Curis Inc. together with Procter & Gamble are developing a hedgehog agonist to be used as a drug for treatment of hair growth disorders. This failed due to toxicities found in animal models.
Disruption of hedgehog signaling during embryonic development, either through deleterious mutation or consumption of teratogens by the gestating mother, can lead to severe developmental abnormalities. Holoprosencephaly, the failure of the embryonic prosencephalon to divide to form cerebral hemispheres, occurs with a frequency of about 1 in 16,000 live births and about 1 in 200 spontaneous abortions in humans and is commonly linked to mutations in genes involved in the hedgehog pathway, including SHH and PTCH. Cyclopia, one of the most severe defects of holoprosencephaly, results if the pathway inhibitor cyclopamine is consumed by gestating mammals.
Activation of the hedgehog pathway has been implicated in the development of cancers in various organs, including brain, lung, mammary gland, prostate and skin. Basal cell carcinoma, the most common form of cancerous malignancy, has the closest association with hedgehog signaling. Loss-of-function mutations in Patched and activating mutations in Smoothened have been identified in patients with this disease. Abnormal activation of the pathway probably leads to development of disease through transformation of adult stem cells into cancer stem cells that give rise to the tumor. Cancer researchers hope that specific inhibitors of hedgehog signaling will provide an efficient therapy for a wide range of malignancies.
Biotech companies are also attempting to turn this pathway on after a patient has a stroke or heart attack. Since the pathway has been implicated in a number of lethal cancers Curis and Wyeth have devised a stable hedgehog protein that can cross the blood brain barrier. In pre-clinical animal models it has shown that the pathway is up regulated upon a stroke or heart attack event. The pathway provides a protective barrier against cell death and ischemia. Agonizing the pathway this way allows the PTCH to be up regulated providing a negative feedback system. This might help minimize the side effects.
Targeting the Hedgehog Pathway
The most common way to target this pathway is modulate SMO. Antagonist and agonist of SMO have already shown to effect the pathway regulation downstream. PTCH and Gli3 (5E1) antibodies are also a way to regulate the pathway. A downstream effector and strong transcriptional activator siRNA Gli1 has been used to inhibit cell growth and promote apoptosis.
Hedgehog Pathway and Metastasis
Hedgehog Pathway and Tumor Regulation
Activation of the Hedgehog pathway leads to an increase in Angiogenic Factors (angiopoietin-1 and angiopoietin-2), Cyclins (cyclin D1 and B1)), anti-apoptotic genes and a decrease in apoptotic genes (Fas).
Hedgehog-like genes, 2 Patched homologs and Patched-related genes exist in the worm C. elegans  . These genes have been shown to code for proteins that have roles in C. elegans development. The hedgehog-like and Patched-related gene families are very large and function without the need for a Smoothened homolog, suggesting a distinct pattern of selection for cholesterol modification and sensing mechanisms in coelomate and pseudo-coelomate lineages.
Lancelets, which are primitive chordates, possess only one homologue of Drosophila Hh (figure 7). Vertebrates, on the other hand, have several hedgehog ligands that fall within three subgroups - desert, indian and sonic, each represented by a single mammalian gene. This is probably a consequence of the two genome duplications that occurred early in the vertebrate evolutionary history. Two such events would have produced four homologous genes, one of which must have been lost. Desert hedgehogs are the most closely related to Drosophila Hh. Additional gene duplications occurred within some species such as the zebrafish Danio rerio, which has an additional tiggywinkle hedgehog gene in the sonic group. Various vertebrate lineages have adapted hedgehogs to unique developmental processes. For example, a homologue of the X.laevis banded hedgehog is involved in regeneration of the salamander limb.
shh has undergone accelerated evolution in the primate lineage leading to humans. Dorus et al hypothesise that this allowed for more complex regulation of the protein and may have played a role in the increase in volume and complexity of the human brain.
The frizzled family of WNT receptors have some sequence similarity to Smoothened . However, G proteins have been difficult to link to the function Smoothened. Smoothened seems to be a functionally divergent member of the G protein coupled receptor super family. Other similarities between the WNT and Hh signaling pathways have been reviewed. Nusse observed that, "a signaling system based on lipid-modified proteins and specific membrane translocators is ancient, and may have been the founder of the Wnt and Hh signaling systems".
It has been suggested that invertebrate and vertebrate signaling downstream from Smoothened has diverged significantly. The role of Suppressor of Fused (SUFU) has been enhanced in vertebrates compared to Drosophila where its role is relatively minor. Costal-2 is particularly important in Drosophila. The protein kinase Fused is a regulator of SUFU in Drosophila, but may not play a role in the Hh pathway of vertebrates. In vertebrates, Hh signalling has been heavily coupled to cilia 
Research is currently being done by Robbie Bayly at the University of Texas at Austin to further understand the effects of the hedgehog signaling pathway on embryonic chicken brain matter.
Thomas Jessel --Hedgehog pathway and Cell Differentiation
Matthew Scott --Cholesterol, Embryonic development, and Disease
Philip Beachy Profile Stanford --Hedgehog Signaling in Development and Disease
James Chen --Small molecule modulation of Hedgehog signaling
- Sonic hedgehog, best studied ligand of the vertebrate pathway
- Smoothened, the conserved GPCR component of the pathway
- Cyclopamine, a small molecule inhibitor of Hh signaling
- http://hedgehog.sfsu.edu (Hedgehog Pathway Database)
- ↑ 1995 Nobel Prize for discovery of the genetic control of early embryonic development
- ↑ Nusslein-Volhard C and Wieschaus E (1980) "Mutations affecting segment number and polarity in Drosophila" in Nature Volume 287, pages 795-801.Entrez PubMed 6776413
- ↑ Mohler J (1988) "Requirements for hedgehog, a segmental polarity gene, in patterning larval and adult cuticle of Drosophila" in Genetics Volume 120, pages 1061-1072.Entrez PubMed 3147217
- ↑ 4.0 4.1 Collins RT and Cohen SM (2005) "A genetic screen in Drosophila for identifying novel components of the hedgehog signaling pathway" in Genetics Volume 170, pages 173-184 Entrez PubMed 15744048
- ↑ 5.0 5.1 Lum L and Beachy PA (2004) "The Hedgehog response network: sensors, switches, and routers" in Science Volume 304, pages 1755-1759 Entrez PubMed 15205520
- ↑ Chen W, Ren XR, Nelson CD, Barak LS, Chen JK, Beachy PA, de Sauvage F and Lefkowitz RJ (2004) "Activity-dependent internalization of smoothened mediated by beta-arrestin 2 and GRK2" in Science Volume 306, pages 2257-2260.Entrez PubMed 15618519
- ↑ Alcedo J, Zou Y and Noll M (2000) "Posttranscriptional regulation of smoothened is part of a self-correcting mechanism in the Hedgehog signaling system" in Molecular Cell Volume 6, pages 457-465. Entrez PubMed 10983991
- ↑ Apionishev S, Katanayeva NM, Marks SA, Kalderon D and Tomlinson A (2005) "Drosophila Smoothened phosphorylation sites essential for Hedgehog signal transduction" Nature Cell Biology Volume 7, page 86-92. Entrez PubMed 15592457
- ↑ Ho KS, Suyama K, Fish M and Scott MP (2005) "Differential regulation of Hedgehog target gene transcription by Costal2 and Suppressor of Fused" in Development Volume 132, pages 1401-1412. Entrez PubMed 15750186
- ↑ Von Ohlen T, Lessing D, Nusse R and Hooper JE (1997) "Hedgehog signaling regulates transcription through cubitus interruptus, a sequence-specific DNA binding protein" in Proceedings of the National Academy of Sciences of the United States of America Volume 94, pages 2404-2409. Entrez PubMed 9122207
- ↑ 11.0 11.1 11.2 Ingham PW and McMahon AP (2001) "Hedgehog signaling in animal development: paradigms and principles" in Genes Dev Volume 15 (23), pages 3059-3087 Entrez PubMed 11731473
Ingham and McMahon review the roles of hedgehog proteins in development; this table provides a summary.
- ↑ Taipale J, Cooper MK, Maiti T, and Beachy PA (2002) "Patched acts catalytically to suppress the activity of Smoothened" in Nature Volume 418, pages 892-897. Entrez PubMed 12192414
- ↑ Davies,J.P,J.P., Chen,F.W., and Ioannou,Y.A (2000) "Transmembrane molecular pump activity of Niemann-Pick C1 protein." in Science Volume 5500, pages 2295-2298. Entrez PubMed 1125140
- ↑ Strutt,H., Thomas,C., Nakano,Y., Stark,D., Neave,B., Taylor,A.M., and Ingham,P.W. (2001) "Mutations in the sterol-sensing domain of Patched suggest a role for vesicular trafficking in Smoothened regulation." in Curr Biol. Volume 8, pages 608-613. Entrez PubMed 11369206
- ↑ Corcoran RB, Scott MP (2006) "Oxysterols stimulate Sonic hedgehog signal transduction and proliferation of medulloblastoma cells." in Proc Natl Acad Sci U S A Volume 418, pages 8408-8413. Entrez PubMed 167075754
- ↑ Rahnama F, Shimokawa T, Lauth M, Finta C, Kogerman P, Teglund S, Toftgard R and Zaphiropoulos PG (2006) "Inhibition of GLI1 gene activation by Patched1" in Biochem J Volume 394, pages 19-26 Entrez PubMed 16229683
- ↑ 17.0 17.1 Carpenter D, Stone DM, Brush J, Ryan A, Armanini M, Frantz G, Rosenthal A and de Sauvage FJ (1998) "Characterization of two patched receptors for the vertebrate hedgehog protein family" in PNAS Volume 95 (23), pages 13630-13634 Entrez PubMed 9811851
- ↑ Rahnama F, Toftgard R and Zaphiropoulos PG (2004) "Distinct roles of PTCH2 splice variants in Hedgehog signalling" in Biochem J Volume 378(Pt 2), pages 325-334 Entrez PubMed 14613484
- ↑ Zaphiropoulos PG, Unden AB, Rahnama F, Hollingsworth RE and Toftgard R (1999) "PTCH2, a novel human patched gene, undergoing alternative splicing and up-regulated in basal cell carcinomas" in Cancer Res Volume 59 (4), pages 787-792 Entrez PubMed 10029063
- ↑ Incardona JP, Lee JH, Robertson CP, Enga K, Kapur RP and Roelink H (2000) "Receptor-mediated endocytosis of soluble and membrane-tethered Sonic hedgehog by Patched-1" in PNAS Volume 97 (22), pages 12044-12049 Entrez PubMed 11027307
- ↑ Jeong J and McMahon AP (2005) "Growth and pattern of the mammalian neural tube are governed by partially overlapping feedback activities of the hedgehog antagonists patched 1 and Hhip1" in Development Volume 132 (1), pages 143-154 Entrez PubMed 15576403
- ↑ Harfe BD, Scherz PJ, Nissim S, Tian H, McMahon AP and Tabin CJ (2004) "Evidence for an expansion-based temporal Shh gradient in specifying vertebrate digit identities" in Cell Volume 118 (4), pages 517-528 Entrez PubMed 15315763
- ↑ Bhardwaj G, Murdoch B, Wu D, Baker DP, Williams KP, Chadwick K, Ling LE, Karanu FN and Bhatia M (2001) "Sonic hedgehog induces the proliferation of primitive human haematopoetic cells via BMP regulation" in Nat Immunol Volume 2 (2), pages 172-180 Entrez PubMed 11175816
- ↑ Liu S, Dontu G, Mantle ID, Patel S, Ahn NS, Jackson KW, Suri P and Wicha MS (2006) "Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells" in Cancer Res Volume 66 (12), pages 6063-6071 Entrez PubMed 16778178
- ↑ Ahn S and Joyner AL (2005) "In vivo analysis of quiescent adult neural stem cells responding to Sonic hedgehog" in Nature Volume 437 (7060), pages 894-897 Entrez PubMed 16208373
- ↑ Paladini RD, Saleh J, Qian C, Xu GX and Rubin LL (2005) "Modulation of hair growth with small molecule agonists of the hedgehog signaling pathway" in J Invest Dermatol Volume 125 (4), pages 638-646 Entrez PubMed 16185261
- ↑ http://www.curis.com/product_detail.php?id=5, retrieved on 25 June 2006.
- ↑ , retrieved on May 9, 2007.
- ↑ OMIM Holoprosencephaly, updated 16 May 2006 Online 'Mendelian Inheritance in Man' (OMIM) 236100
- ↑ Keeler RF (1978) "Cyclopamine and related steroidal alkaloid teratogens: their occurrence, structural relationship, and biologic effects" in Lipids Volume 13 (10), pages 708-715 Entrez PubMed 723484
- ↑ Xie J, Murone M, Luoh SM, Ryan A, Gu Q, Zhang C, Bonifas JM, Lam CW, Hynes M, Goddard A et al (1998) "Activating Smoothened mutations in sporadic basal-cell carcinoma" in Nature Volume 391 (6662), pages 90-92 Entrez PubMed 9422511
- ↑ Chen JK, Taipale J, Young KE, Maiti T and Beachy PA (2002) "Small molecule modulation of Smoothened activity" in PNAS Volume 99 (22), pages 14071-14076 Entrez PubMed 12391318
- ↑ Curis pipeline details Stroke and Heart Attack
- ↑ Nakamura M, Kubo M, Yanai K, Mikami Y, Ikebe M, Nagai S, Yamaguchi K, Tanaka M, Katano M. (2007) "Anti-patched-1 antibodies suppress hedgehog signaling pathway and pancreatic cancer proliferation." in Anticancer Res. (6A), pages 3743-7. Entrez PubMed 17970037
- ↑ Hunt R, Bragina O, Drews M, Kasak L, Timmusk S, Valkna A, Kogerman P, Järvekülg L. (2007) "Generation and characterization of mouse monoclonal antibody 5E1 against human transcription factor GLI3." in Hybridoma (4), pages 231-40 Entrez PubMed 17725385
- ↑ Stecca B, Mas C, Ruiz i Altaba A. (2005) "Interference with HH-GLI signaling inhibits prostate cancer." in Trends Mol Med. (5), pages 199-203 Entrez PubMed 15882606
- ↑ Xingnan Li, Wentao Deng, Clinton D. Nail, Sarah K. Bailey, Matthias H. Kraus, J. Michael Ruppert, and Susan M. Lobo-Ruppert1 (2006) "Snail induction is an early response to Gli1 that determines the efficiency of epithelial transformation" in Oncogene. Volume 99 (4), pages 609-621 Entrez PubMed 16158046
- ↑ (2007) "Sonic hedgehog inversely regulates the expression of angiopoietin-1 and angiopoietin-2 in fibroblasts." in Int J Mol Med. Volume 99 (3), pages 445-51 Entrez PubMed 17273793
- ↑ (2006) "Patched1 functions as a gatekeeper by promoting cell cycle progression." in Cancer Res. Volume 99 (5), pages 2081-8. Entrez PubMed 16489008
- ↑ (2004) "Inhibition of smoothened signaling prevents ultraviolet B-induced basal cell carcinomas through regulation of Fas expression and apoptosis." in Cancer Res. Volume 99 (5), pages 7545-52. Entrez PubMed 15492281
- ↑ 41.0 41.1 Zugasti O, Rajan J and Kuwabara PE (2005) "The function and expansion of the Patched- and Hedgehog-related homologs in C. elegans" in Genome Research Volume 15, pages 1402-1410.Entrez PubMed 16204193
- ↑ 42.0 42.1 Novatchkova M, Wildpaner M, Schweizer F and Eisenhaber F (2005) "PhyloDome--visualization of taxonomic distributions of domains occurring in eukaryote protein sequence sets" in Nucleic Acids Research Volume 33(Web Server issue):W121-5.Entrez PubMed 15980439
- ↑ Wada H, and Makabe K (2006) "Genome duplications of early vertebrates as a possible chronicle of the evolutionary history of the neural crest" in International Journal of Biological Science Volume 2 (3), pages 133-141. Entrez PubMed 16763673
- ↑ Stark DR, Gates PB, Brockes JP and Ferretti P (1998) "Hedgehog family member is expressed throughout regenerating and developing limbs" in Dev Dyn Volume 212 (3), pages 352-363 Entrez PubMed 9671939
- ↑ Dorus S, Anderson JR, Vallender EJ, Gilbert SL, Zhang L, Chemnick LG, Ryder OA, Li W and Lahn BT (2006) "Sonic Hedgehog, a key development gene, experienced intensified molecular evolution in primates" in Human Molecular Genetics Volume 15 (13), pages 2031-2037. Entrez PubMed 16687440
- ↑ Graul RC and Sadee W (2001) "Evolutionary relationships among G protein-coupled receptors using a clustered database approach" in AAPS PharmSci Volume 3 article E12.Entrez PubMed 11741263
- ↑ Nusse R (2003) "Wnts and Hedgehogs: lipid-modified proteins and similarities in signaling mechanisms at the cell surface" in Development Volume 130, pages 5297-5305. Entrez PubMed 14530294
- ↑ Varjosalo M, Li SP and Taipale J (2006) "Divergence of hedgehog signal transduction mechanism between Drosophila and mammals" in Developmental cell Volume 10, pages 177-186.Entrez PubMed 16459297.
- ↑ Chen MH, Gao N, Kawakami T and Chuang PT (2005) "Mice deficient in the fused homolog do not exhibit phenotypes indicative of perturbed hedgehog signaling during embryonic development" in Molecular Cell Biology Volume 25, pages 7042-7053.Entrez PubMed 16055716.
- ↑ Huangfuand D and Anderson KV (2006) "Signaling from Smo to Ci/Gli: conservation and divergence of Hedgehog pathways from Drosophila to vertebrates" in Development Volume 133, pages 3-14. Entrez PubMed 16339192.
|Key concepts||Ligand - Signal transduction - Apoptosis - Second messenger system (Ca2+ signaling, Lipid signaling)|
|Processes||Paracrine - Autocrine - Juxtacrine - Neurotransmitters - Endocrine (Neuroendocrine)|
|Types of proteins||Receptor (Transmembrane, Intracellular) - Transcription factor (General, Preinitiation complex, TFIID, TFIIH) - Adaptor protein|
|receptor ligands||hormones, neurotransmitters, cytokines, growth factors|
Animal intercellular signaling peptides and proteins
|Growth factors||Epidermal growth factor - Fibroblast growth factor (FGF2) - Nerve growth factor - Platelet-derived growth factor - Transforming growth factor (TGFα, TGFβ, TGFβ pathway)|
|Other||Hedgehog (Sonic hedgehog) - Integrin - JAK/STAT (JAK/STAT) - MAPK/ERK pathway (MAPK/ERK) - NF-κB - Notch (1, 2, 3) - p53 - Wnt (WNT4, Frzb)|
There is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies